Cognetivity Neurosciences Ltd C.CGN

Alternate Symbol(s): CGNSF

Healthcare Medical Devices

Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. It is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.

CSE:CGN - Post by User

Cognetivity Neurosciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by AwareInvestoron Oct 20, 2021 9:23am

97 Views

Post# 34026292

Cognetivity Neurosciences Sees Granting Of FDA Clearance For

Cognetivity Neurosciences has reached a major achievement. The company has been granted FDA clearance from the US Food and Drug Administration for the distribution of its integrated cognitive assessment. The approval essentially enables the company to market its device for use within the US market.

https://thedeepdive.ca/cognetivity-neurosciences-sees-granting-of-fda-clearance-for-cognitive-assessment-tool/

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks